United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coloplast ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coloplast ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coloplast ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

coloplast ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

3m health care ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

3m health care ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

3m health care ltd -

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

pharmatrade united kingdom - 30's [30 pouches of 5 x 5 cm] 3755 - dressing - device - skin-wound management

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30's [30 pouches of 5 x 5 cm] 3755 -

Israel - English - Ministry of Health

alphamedix ltd, israel - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 0.8 ng 100 ld50 units / vial - botulinum toxin - xeomin is indicated for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adult. xeomin is indicated for the temporary improvement in the appearance of moderate to severe vertical lines between eyebrows seen at frown (glabellar frown lines) in adults below 65 years when the severity of these lines has an important psychological impact for the patient